title: Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages.
abstract: The influence of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of freshly isolated normal human peritoneal macrophages and blood monocytes was examined. Each of 14 HIV antibody-positive human serum samples was found to block the infection of four virus isolates (human T-cell lymphotropic virus type IIIBa-L [HTLV-IIIBa-L], HTLV-IIIB, D.U. 6587-7, and D.U. 7887-8) at serum dilutions ranging from 10(-1) to 10(-2). Three of these isolates (HTLV-IIIBa-L, D.U. 6587-7, and D.U. 7887-8) infected cultures of monocytes and macrophages rapidly and produced high levels of virus reverse transcriptase and p24 antigen. A fourth virus isolate (HTLV-IIIB) infected the monocytes and macrophages more slowly and produced low levels of viral protein. More dilute HIV antibody-positive sera had no significant effect on the overall level or rate of virus infection or expression. Complement did not appear to influence the course of infection by any combination of antisera or virus examined. Successful HIV-1 infection of the peritoneal macrophages and blood monocytes under the conditions tested showed strict dependence on CD4 since a recombinant CD4 polypeptide and an anti-CD4 monoclonal antibody effectively blocked the process.
authors.affiliation: Department of Surgery, Duke University, Durham, North Carolina.
authors.forename: P P
authors.initials: PP
authors.lastname: Shadduck
authors.forename: J B
authors.initials: JB
authors.lastname: Weinberg
authors.forename: A F
authors.initials: AF
authors.lastname: Haney
authors.forename: J A
authors.initials: JA
authors.lastname: Bartlett
authors.forename: A J
authors.initials: AJ
authors.lastname: Langlois
authors.forename: D P
authors.initials: DP
authors.lastname: Bolognesi
authors.forename: T J
authors.initials: TJ
authors.lastname: Matthews
mesh_terms: D002478:Cells, Cultured; D003165:Complement System Proteins / Q000502:physiology; D005455:Fluorescent Antibody Technique; D015483:HIV Antibodies / Q000276:immunology* / Q000502:physiology; D015497:HIV-1 / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007700:Kinetics; D008264:Macrophages / Q000382:microbiology*; D009000:Monocytes / Q000382:microbiology*; D010529:Peritoneal Cavity / Q000166:cytology; D012194:RNA-Directed DNA Polymerase / Q000096:biosynthesis
chemical_list: D015483:HIV Antibodies; D003165:Complement System Proteins; D012194:RNA-Directed DNA Polymerase